Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5221763 | SUCAMPO PHARMA LLC | Prostaglandins of the F series |
Jul, 2012
(11 years ago) | |
US6770675 | SUCAMPO PHARMA LLC | Compositions and methods for reducing ocular hypertension |
Nov, 2018
(5 years ago) | |
US6458836 | SUCAMPO PHARMA LLC | Treatment of ocular hypertension and glaucoma |
Jul, 2021
(2 years ago) |
Market Authorisation Date: 03 August, 2000
Treatment: Method of reducing ocular hypertension; Method of treating ocular hypertension
Dosage: SOLUTION/DROPS;OPHTHALMIC